seqirus.com
Seqirus Worldwide
|
CSL Limited
Search
Include All CSL Behring Country Sites
About Seqirus Worldwide
Products
Newsroom
Careers
Contacts
Home
> Home
Our Products
With cutting-edge facilities, technologies and technical expertise, Seqirus will be a reliable supplier of seasonal influenza vaccine with the ability to rapidly respond to pandemic threats.
Read More >
Features
Welcome to Seqirus
In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now the second ...
News
Seqirus announces next major advancement in cell-based influenza vaccine technology
21-Jun-2017
Seqirus, a leading innovator in influenza ...
Seqirus receives FDA approval for AFLURIA® QUADRIVALENT (Influenza Vaccine) for people 18 years of age and older
29-Aug-2016
Seqirus announced today that the US Food and ...
Seqirus Presents Integrated Analyses for Trivalent Adjuvanted Seasonal Influenza Vaccine for Young Children
24-Aug-2016
Seqirus today announced results of two data ...